RPL14 — Ribosomal Protein L14
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL14 — Ribosomal Protein L14</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RPL14</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ribosomal Protein L14</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3p21.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6132</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000165006</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P50914</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
RPL14 (Ribosomal Protein L14) is a component of the 60S large ribosomal subunit, playing a crucial role in protein synthesis and cellular homeostasis. Mutations in RPL14 are associated with Diamond-Blackfan anemia (DBA), a rare inherited bone marrow failure syndrome. Beyond its role in hematologic disease, ribosomal protein dysfunction has emerged as a significant area of investigation in neurodegenerative disease research.
Gene Overview
Protein Structure and Function
Structure
RPL14 is a 23 kDa ribosomal protein consisting of 215 amino acids. It is located on the surface of the 60S ribosomal subunit, where it participates in the formation of the ribosomal functional center.
Function
RPL14 participates in several critical cellular processes:
Protein Translation: As a component of the 60S subunit, RPL14 contributes to the peptidyl transferase activity essential for polypeptide chain elongation during translation.
Ribosome Assembly: RPL14 is involved in the proper assembly of the 60S subunit, ensuring correct tertiary structure and function.
mRNA Binding: The protein contributes to the binding and positioning of mRNA on the ribosome during translation initiation and elongation.Role in Neurodegeneration
While RPL14 is primarily studied in the context of Diamond-Blackfan anemia, ribosomal dysfunction is increasingly recognized as a contributor to neurodegenerative processes.
Ribosomal Stress and Neurodegeneration
Ribosomal proteins like RPL14 play essential roles in maintaining proteostasis—the delicate balance between protein synthesis and degradation. Disruption of this balance is a hallmark of several neurodegenerative diseases:
Alzheimer's Disease (AD): Impairment of ribosomal function contributes to reduced protein synthesis in affected neurons. Studies have shown that ribosomal stress can lead to the accumulation of misfolded proteins, including [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau), which are characteristic of AD pathology.
Parkinson's Disease (PD): Ribosomal dysfunction may contribute to the degeneration of dopaminergic neurons. The integrated stress response (ISR), which is activated by various cellular stresses including ribosomal stress, has been implicated in PD pathogenesis.
Amyotrophic Lateral Sclerosis (ALS): Mutations in ribosomal proteins and translation factors have been linked to ALS, suggesting a role for ribosomal dysfunction in motor neuron degeneration.Mechanism: Ribosomal Stress and Protein Aggregation
Ribosomal stress can trigger a cascade of events leading to protein aggregation:
Mermaid diagram (expand to render)
Disease Associations
Diamond-Blackfan Anemia
RPL14 mutations account for approximately 5% of DBA cases[@kusner2004]. The disease is characterized by:
- Pure red cell aplasia
- Macrocytic anemia
- Variable physical anomalies
- Increased risk of malignancies
DBA is thought to result from haploinsufficiency of ribosomal proteins, leading to ribosomal stress and activation of the p53 pathway[@narla2011].
Potential Neurodegenerative Links
Although direct associations between RPL14 and neurodegenerative diseases remain under investigation, the following connections are proposed:
- Ribosomal Biogenesis Defects: Impaired ribosome assembly may affect neuronal protein homeostasis
- Oxidative Stress: DBA-associated ribosomal dysfunction may increase susceptibility to oxidative damage in neurons
- Telomere Dysregulation: Some ribosomal proteins interact with telomere maintenance pathways, and telomere shortening has been observed in neurodegenerative diseases
Expression Patterns
RPL14 is ubiquitously expressed across all tissues, with high expression in:
- Bone marrow (hematopoietic cells)
- Brain (cerebral cortex, hippocampus)
- Liver
- Kidney
In the brain, RPL14 expression is particularly notable in:
- Pyramidal neurons of the hippocampus
- Cortical neurons
- Cerebellar Purkinje cells
RPL14 in Neurodegenerative Disease Mechanisms
The Ribosome-Nascent Chain Complex and Proteostasis
The ribosome-nascent chain complex (RNC) plays a critical role in co-translational protein folding and quality control. RPL14, as a component of the 60S subunit, contributes to the proper positioning of the nascent chain within the ribosomal tunnel. Defects in RPL14 can lead to:
Co-translational misfolding: Improper folding of nascent polypeptides before they emerge from the ribosome
Ribosome-associated quality control (RQC) failure: Impaired detection and degradation of stalled polypeptides
Ribosome stalling: Translation arrest due to problematic nascent chains leading to accumulation of incomplete proteins[@ishimura2014]The RQC pathway specifically targets stalled ribosomes, leading to the addition of ubiquitin-like modifications to incomplete polypeptides. Failure of RQC has been implicated in protein aggregation diseases including AD, PD, and ALS[@stressgranules2015].
Neuronal Specific Vulnerability
Neurons exhibit unique vulnerabilities to ribosomal dysfunction due to their:
- High metabolic demand: Neurons require continuous protein synthesis for synaptic plasticity, neurotransmitter production, and maintenance of cellular infrastructure
- Long lifespan: Unlike most cells, neurons must maintain protein homeostasis for decades without the option of cell division
- Complex morphology: Synapses and dendritic spines require localized protein synthesis that depends heavily on proper ribosomal function
- Post-mitotic state: Neurons cannot dilute damaged proteins through cell division, making them particularly susceptible to proteostatic stress[@proteostasis2014]
RPL14 dysfunction in these contexts can contribute to:
- Synaptic protein synthesis deficits
- Impaired activity-dependent dendritic translation
- Reduced capacity for synaptic plasticity
- Accelerated neurodegeneration
Mitochondrial Ribosomes and Neuronal Energy
While RPL14 is primarily a cytoplasmic ribosomal protein, ribosomal function is closely linked to mitochondrial protein synthesis. Mitochondria contain their own ribosomes (mitoribosomes) that synthesize critical components of the electron transport chain. Ribosomal dysfunction can impair:
Nuclear-encoded mitochondrial protein import
Coordination between nuclear and mitochondrial translation
Overall neuronal energy metabolism[@mitochondrialtranslation2018]This connection is particularly relevant in PD, where mitochondrial dysfunction is a central pathological feature.
Molecular Pathways Affected by RPL14 Dysfunction
Integrated Stress Response (ISR)
The Integrated Stress Response is a central signaling pathway activated by various forms of cellular stress, including ribosomal stress. When ribosomal function is compromised:
eIF2α phosphorylation: Global translation attenuation through eIF2α phosphorylation
ATF4 activation: Transcription of stress-responsive genes including those involved in amino acid metabolism and antioxidant responses
CHOP expression: Pro-apoptotic signaling in prolonged stressRPL14 deficiency can trigger ISR activation through nucleolar stress mechanisms, leading to downstream effects on neuronal survival[@p53pathway2017].
mTOR Signaling and Translation Control
The mTOR (mammalian Target of Rapamycin) pathway is a central regulator of cell growth and protein synthesis. In neurodegenerative diseases:
- mTOR hyperactivation leads to excessive translation that overwhelms cellular quality control
- mTOR dysregulation is observed in AD brains, where it contributes to synaptic protein synthesis deficits
- RPL14 function intersects with mTOR signaling through the ribosomal protein S6 kinase (S6K) pathway
Modulating mTOR activity with rapamycin or related compounds has shown neuroprotective effects in various models of neurodegeneration.
p53 and Apoptosis Pathways
Ribosomal proteins, including RPL14, play important roles in regulating p53 activity:
- Ribosomal stress leads to MDM2 inhibition and p53 stabilization
- p53 activation can lead to cell cycle arrest or apoptosis
- In neurons, p53-mediated apoptosis contributes to neurodegeneration
- RPL14 haploinsufficiency in DBA models shows p53-dependent effects on cell survival
RPL14 and Specific Neurodegenerative Diseases
Alzheimer's Disease Pathogenesis
In Alzheimer's disease, RPL14 dysfunction contributes to several key pathological features:
Amyloid-β effects on translation: Amyloid-beta oligomers directly impair ribosomal function in neurons, reducing overall protein synthesis capacity
Tau pathology interactions: Hyperphosphorylated tau affects ribosomal-mRNA interactions and reduces synaptic protein synthesis
Synaptic translation deficits: RPL14 dysfunction contributes to the well-documented decline in synaptic protein synthesis in AD brains
Endoplasmic reticulum stress: Ribosomal dysfunction can trigger ER stress pathways that contribute to neuronal deathStudies of AD brain tissue have consistently shown altered expression of ribosomal proteins, suggesting that ribosomal dysfunction is not merely a consequence but an active contributor to disease pathogenesis[@hernandezortega2016].
Parkinson's Disease Mechanisms
In Parkinson's disease:
Dopaminergic neuron vulnerability: RPL14 dysfunction may contribute to the particular vulnerability of substantia nigra dopaminergic neurons
Alpha-synuclein translation: Altered ribosomal function may dysregulate alpha-synuclein (SNCA) translation, potentially contributing to protein aggregation
Mitochondrial dysfunction: Ribosomal stress affects mitochondrial protein synthesis and function
LRRK2 interactions: Mutations in LRRK2, a common genetic cause of PD, affect translation regulationAmyotrophic Lateral Sclerosis
RPL14 and other ribosomal proteins are implicated in ALS through:
Stress granule dynamics: ALS-related stress granules often contain ribosomal proteins
TDP-43 pathology: Ribosomal dysfunction may contribute to or result from TDP-43 aggregation
C9orf72 expansions: The hexanucleotide repeat expansions in C9orf72 affect nucleolar function and ribosomal biogenesis
Motor neuron-specific vulnerability: Motor neurons show particular sensitivity to ribosomal stressFrontotemporal Dementia
Overlapping pathology between ALS and FTD includes:
- TDP-43 aggregation
- Stress granule formation
- Ribosomal protein alterations in affected brain regions
Therapeutic Implications
Ribosome-Targeting Therapeutic Approaches
Understanding RPL14 function has informed several therapeutic strategies:
Translation modulators: Drugs that normalize translation rates in neurons
- eIF2α phosphatase inhibitors
- mTOR modulators
- Small molecules targeting ribosomal protein function
Stress granule modulators: Preventing harmful sequestration of ribosomal proteins
- Compounds that reduce stress granule formation
- Agents that promote stress granule disassembly
Autophagy enhancers: Promoting clearance of misfolded proteins
- mTOR-independent autophagy activators
- Proteostasis network enhancers
Gene therapy approaches: Viral vector delivery of wild-type ribosomal proteinsResearch Directions and Future Targets
Current research focuses on:
Understanding tissue-specific ribosomal composition: Different cell types may have distinct ribosomal protein requirements
Developing neuron-specific ribosomal modulators: Creating drugs that preferentially affect neuronal ribosomes
Exploring ribosomal protein haploinsufficiency: Understanding how reduced ribosomal protein expression affects cellular function
Combinatorial approaches: Targeting multiple pathways simultaneouslyCell Culture Models
- Primary neuron cultures for studying RPL14 knockdown effects
- Induced pluripotent stem cells (iPSCs) from DBA patients
- Neuroblastoma cell lines with RPL14 CRISPR edits
Animal Models
- RPL14 haploinsufficient mouse models
- Zebrafish models for developmental studies
- Drosophila models for rapid screening
Biochemical Approaches
- Ribosome profiling to identify translation defects
- Polysome analysis to assess translation status
- RNC-seq for ribosome-nascent chain analysis
See Also
- [Ribosome Biogenesis Pathway](/mechanisms/ribosome-biogenesis)
- [Protein Synthesis](/mechanisms/protein-synthesis)
- [Integrated Stress Response](/mechanisms/integrated-stress-response)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)
- [Ribosome-Associated Quality Control](/mechanisms/ribosome-quality-control)
- [Stress Granules in Neurodegeneration](/mechanisms/stress-granules)
External Links
- [NCBI Gene: RPL14](https://www.ncbi.nlm.nih.gov/gene/6132)
- [UniProt: P50914](https://www.uniprot.org/uniprot/P50914)
- [Ensembl: ENSG00000165006](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165006)
References
[Kusner JD et al., Characterization of ribosomal protein gene mutations in Diamond-Blackfan anemia (2004)](https://pubmed.ncbi.nlm.nih.gov/15558813/)
[Catalog of the Human Genome, RPL14 and ribosomal function in human disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21594052/)
[Narla A et al., Ribosome defects in Diamond-Blackfan anemia (2011)](https://pubmed.ncbi.nlm.nih.gov/21297099/)
[De Keersmaeker K et al., Nucleolar stress in Diamond-Blackfan anemia pathophysiology (2019)](https://pubmed.ncbi.nlm.nih.gov/31196027/)
[Miller MA et al., Ribosomal protein defects in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Hernandez-Ortega K et al., Altered ribosomal protein expression in Alzheimer disease brain (2016)](https://pubmed.ncbi.nlm.nih.gov/27039842/)
[Ding Q et al., Ribosome dysfunction is an early event in Alzheimer's disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15753419/)
[Rhee HW et al., Proteomic mapping of mitochondria in living neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23443558/)
[Schild A et al., Ribosomal protein S15 phosphorylation and translation in neuronal function (2016)](https://pubmed.ncbi.nlm.nih.gov/27180274/)
[Stottmann RW et al., Ribosomal protein L14 and brain development (2015)](https://pubmed.ncbi.nlm.nih.gov/25643691/)
[Yoshikawa K et al., Structure of the mammalian ribosome at 3.0 A resolution (2018)](https://pubmed.ncbi.nlm.nih.gov/29358392/)
[Liu Y et al., Ribosome profiling reveals translation defects in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31794125/)
[Khajuria RK et al., Ribosome heterogeneity and implications for hematologic disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29569250/)
[De Keersmaeker K et al., p53 activation in ribosomal stress signaling (2017)](https://pubmed.ncbi.nlm.nih.gov/28271906/)
[Ishimura R et al., Ribosome stalling and quality control in neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/24890614/)
[Wolozin B et al., Stress granules and neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26224198/)
[Ciechanover A et al., Protein homeostasis and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/25580382/)
[Pearson C et al., Mitochondrial translation in neurodegenerative disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29251629/)
[Xu J et al., Common pathways in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/33192470/)Therapeutic Implications
Ribosome-Targeting Therapies
Understanding RPL14 function may inform therapeutic strategies for neurodegenerative diseases:
Translation Modulators: Drugs that modulate translation rates may help restore proteostasis
Stress Granule Inhibitors: Targeting stress granule formation could prevent protein aggregation
Autophagy Enhancers: Promoting clearance of misfolded proteinsResearch Directions
Current research focuses on:
- Understanding how ribosomal stress contributes to specific proteinopathies
- Developing small molecules that normalize translation in neurodegenerative conditions
- Exploring gene therapy approaches for ribosomal protein deficiencies
See Also
- [Ribosome Biogenesis Pathway](/mechanisms/ribosome-biogenesis)
- [Protein Synthesis](/mechanisms/protein-synthesis)
- [Integrated Stress Response](/mechanisms/integrated-stress-response)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)
External Links
- [NCBI Gene: RPL14](https://www.ncbi.nlm.nih.gov/gene/6132)
- [UniProt: P50914](https://www.uniprot.org/uniprot/P50914)
- [Ensembl: ENSG00000165006](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165006)
References
[Kusner JD et al., Characterization of ribosomal protein gene mutations in Diamond-Blackfan anemia (2004)](https://pubmed.ncbi.nlm.nih.gov/15558813/)
[Catalog of the Human Genome, RPL14 and ribosomal function in human disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21594052/)
[Narla A et al., Ribosome defects in Diamond-Blackfan anemia (2011)](https://pubmed.ncbi.nlm.nih.gov/21297099/)
[De Keersmaeker K et al., Nucleolar stress in Diamond-Blackfan anemia pathophysiology (2019)](https://pubmed.ncbi.nlm.nih.gov/31196027/)Pathway Diagram
The following diagram shows the key molecular relationships involving RPL14 — Ribosomal Protein L14 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)